$RPRX
Royalty Pharma plc
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
RPRX chart
What traders are saying about $RPRX
Latest postsRoyalty Pharma plc news
- 143,912 Shares in Royalty Pharma PLC $RPRX Bought by Hohimer Wealth Management LLC
MarketBeat ·
- 25,458 Royalty Pharma PLC $RPRX Shares Sold by Formidable Asset Management LLC
MarketBeat ·
- Royalty Pharma PLC $RPRX Shares Sold by Bryn Mawr Trust Advisors LLC
MarketBeat ·
- What Comes Next For Royalty Pharma After A 78% Gain
Simply Wall St ·
- Royalty Pharma plc (RPRX) Latest Stock News & Headlines - Yahoo Finance
Yahoo! Finance Canada ·
- 3 US Healthcare Dividend Stocks For Higher Rates and Steady Income
Yahoo Finance ·
- Why Royalty Pharma Investors Could Be the Quiet Winners From Revolution Medicines' Groundbreaking Pancreatic Cancer Drug
fool.com ·
- Royalty Pharma (RPRX) Beat Third Quarter Expectations, Is The Stock Now Overvalued?
Simply Wall St ·
- Royalty Pharma PLC (RPRX) - What Are Brokerages Thinking About This Stock?
MarketBeat ·
- RPRX: Blockbuster Royalties Still Matter, Financing Momentum Now Carries More Of The Case
Simply Wall St ·
- How Investors Are Reacting To Royalty Pharma (RPRX) Earnings Beat
Yahoo Finance ·
- CFO entities convert interests into 250,000 Royalty Pharma (RPRX) shares and acquire 7,122 award shares.
Stock Titan ·
Royalty Pharma plc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.38B | $2.26B | $2.35B | $2.24B |
| Net income | $770.9M | $859.0M | $1.13B | $42.8M |
| Diluted EPS | $1.78 | $1.91 | $2.53 | $0.10 |
| Total assets (year end) | $19.62B | $18.22B | $16.38B | $16.81B |
| Cash and equivalents (year end) | $618.7M | $929.0M | $477.0M | $1.71B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Royalty Pharma plc
- Ticker
- RPRX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- United Kingdom
- Fiscal year end
- December 31
- SEC CIK
- 1802768
Frequently asked questions
What exchange is Royalty Pharma plc listed on?
Royalty Pharma plc trades on the Nasdaq under the ticker symbol RPRX.
What industry is Royalty Pharma plc in?
Royalty Pharma plc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Royalty Pharma plc headquartered?
Royalty Pharma plc's business address on file with the SEC is in New York, NY.
When does Royalty Pharma plc's fiscal year end?
Royalty Pharma plc's fiscal year ends on December 31.
How much revenue did Royalty Pharma plc report?
Royalty Pharma plc reported $2.38B in revenue for calendar year 2025, according to its SEC filings.